IBEX Technologies Inc
XTSX:IBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
IBEX Technologies Inc
Revenue
IBEX Technologies Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IBEX Technologies Inc
XTSX:IBT
|
Revenue
CA$7.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Revenue
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Revenue
$283.1m
|
CAGR 3-Years
28%
|
CAGR 5-Years
41%
|
CAGR 10-Years
107%
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Revenue
$7.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-7%
|
|
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
Revenue
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
e
|
enGene Holdings Inc
NASDAQ:ENGN
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IBEX Technologies Inc
Glance View
IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. The Company’s subsidiaries also include Technologies IBEX R&D Inc., IBEX Technologies Corporation and Bio-Research Products Inc. (BRP).
See Also
What is IBEX Technologies Inc's Revenue?
Revenue
7.8m
CAD
Based on the financial report for Oct 31, 2023, IBEX Technologies Inc's Revenue amounts to 7.8m CAD.
What is IBEX Technologies Inc's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for IBEX Technologies Inc have been 14% over the past three years , 11% over the past five years , and 7% over the past ten years .
